Patents by Inventor Geoffrey T. Swanson

Geoffrey T. Swanson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterotricyclic AMPA receptor antagonists for treatment of epilepsy, pain, and other neurological disorders and diseases
    Patent number: 8895579
    Abstract: Disclosed are heterotricyclic compounds, pharmaceutical compositions, methods of treatment, and methods for selectively antagonizing a glutamate receptor. The pharmaceutical compositions may include and the methods may utilize heterotricyclic compounds that are glutamate analogues which have specificity for AMPA receptors. The pharmaceutical compositions may be utilized to treat or prevent neurological diseases or disorders.
    Type: Grant
    Filed: March 21, 2011
    Date of Patent: November 25, 2014
    Assignee: Northwestern University
    Inventors: Geoffrey T. Swanson, Martin B. Gill, Ryuichi Sakai, Masato Oikawa
  • Heterotricyclic AMPA Receptor Antagonists for Treatment of Epilepsy, Pain, and Other Neurological Disorders and Diseases
    Publication number: 20120071423
    Abstract: Disclosed are heterotricyclic compounds, pharmaceutical compositions, methods of treatment, and methods for selectively antagonizing a glutamate receptor. The pharmaceutical compositions may include and the methods may utilize heterotricyclic compounds that are glutamate analogues which have specificity for AMPA receptors. The pharmaceutical compositions may be utilized to treat or prevent neurological diseases or disorders.
    Type: Application
    Filed: March 21, 2011
    Publication date: March 22, 2012
    Applicant: NORTHWESTERN UNIVERSITY
    Inventors: Geoffrey T. Swanson, Martin B. Gill, Ryuichi Sakai, Masato Oikawa
  • Kainate receptor-selective epimeric analogs of dysiherbaine
    Patent number: 7973075
    Abstract: Disclosed are compounds, pharmaceutical compositions, methods of treatment, and methods for selectively antagonizing a GluR5 receptor, a GluR6 receptor, or both receptors. The pharmaceutical compositions include and the methods utilize compounds that are analogs and stereoisomers of dysiherbaine and neodysiherbaine which have specificity for kainate receptors.
    Type: Grant
    Filed: October 1, 2008
    Date of Patent: July 5, 2011
    Assignee: Northwestern University
    Inventors: Geoffrey T. Swanson, Leanne Lash, Ryuichi Sakai
  • Kainate Receptor-Selective Epimeric Analogs of Dysiherbaine
    Publication number: 20090118358
    Abstract: Disclosed are compounds, pharmaceutical compositions, methods of treatment, and methods for selectively antagonizing a GluR5 receptor, a GluR6 receptor, or both receptors. The pharmaceutical compositions include and the methods utilize compounds that are analogs and stereoisomers of dysiherbaine and neodysiherbaine which have specificity for kainate receptors.
    Type: Application
    Filed: October 1, 2008
    Publication date: May 7, 2009
    Applicant: Northwestern University
    Inventors: Geoffrey T. Swanson, Leanne Lash